Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma

计划入组 16 人 · 首次发布于 2010 年 3 月 31 日

Treatment of Cushing's Disease With R-roscovitine

计划入组 4 人 · 首次发布于 2014 年 6 月 11 日

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma

计划入组 12 人 · 首次发布于 2012 年 7 月 27 日

BT-113

ABM-3249

indenopyrazole/quinazoline CDK inhibitors (BMS)

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

China Approves Xuanyuening (Bireociclib): First Dual-Indication CDK Inhibitor for Advanced Breast Cancer

Roche Acquires Regor Therapeutics' CDK Inhibitors for Breast Cancer Treatment

Roche's Giredestrant Combination Meets Phase III Endpoints in Advanced Breast Cancer